EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Medication Utilization Among Children With Sickle Cell Disease in the United States

Abiodun John Ologunowa iD, Kelly L Matson, Jung Eun Lee, Meghan McCormick, Mary L Greaney, Aisling R Caffrey

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Abiodun John Ologunowa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Practice Patterns, Physicians', Drug Utilization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective The medication management of children with sickle cell disease (SCD), especially since the release of the 2014 National Heart, Lung, and Blood Institute (NHLBI) SCD treatment guidelines, is not well described in the published literature. This study assessed medication utilization trends overall and by patient demographics.

Methods

This retrospective study examined children aged 1–17 years diagnosed with SCD from January 1, 2010 to December 31, 2018, in Optum's de‐identified Clinformatics Data Mart database. Changes in medication utilization over time were assessed using Joinpoint regression. Stratified time trends were evaluated by patient age, sex, race/ethnicity, region, and household income level.

Results

Over the 8‐year study period, a total of 1868 children with SCD were identified. Hydroxyurea prescriptions increased 8.8%, on average, each year of the study period ( p < 0.001), indicating rising adherence to recommended disease‐modifying strategies. Shifts in opioid prescribing showed increased oxycodone use (6.3% average annual increase, p < 0.001) and decreased acetaminophen‐codeine use (24.3% average annual decrease, p < 0.001). Notably, non‐steroidal anti‐inflammatory drug (NSAID) use increased by 4.0% annually ( p = 0.010), reflecting shifts toward alternative pain management strategies. Significant shifts in medication utilization, overall and by patient demographics, were observed since the 2014 NHLBI SCD treatment guidelines were released.

Conclusions

Our study findings underscore the dynamic nature of SCD management in children, and highlight the need for continuous evaluation of treatment guideline adherence, as well as treatment effectiveness and safety with the newer SCD medications and treatment guidelines, to optimize clinical outcomes among this vulnerable patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellPractice Patterns, Physicians'Drug UtilizationHumansChildMaleFemaleAdolescentChild, PreschoolRetrospective StudiesInfantUnited StatesHydroxyureaFollow-Up StudiesPrognosisAnalgesics, Opioid

Stichwörter der Autor:innen

hydroxyureaopioidspediatricssickle cell disease

Substanzen

HydroxyureaAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.
  • Department of Pharmacy, UMass Memorial Health, Worcester, Massachusetts, USA.
  • College of Nursing, University of Rhode Island, Kingston, Rhode Island, USA.
  • Department of Health Studies, University of Rhode Island, Kingston, Rhode Island, USA.

ORCID-Profile: Abiodun John Ologunowa

Zitieren

APA

Ologunowa, A. J., Matson, K. L., Lee, J. E., McCormick, M., Greaney, M. L., & Caffrey, A. R. (2025). Medication Utilization Among Children With Sickle Cell Disease in the United States. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31788

Vancouver

Ologunowa AJ, Matson KL, Lee JE, McCormick M, Greaney ML, Caffrey AR. Medication Utilization Among Children With Sickle Cell Disease in the United States. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31788

BibTeX
@article{Ologunowa2025,
  author = {Ologunowa, Abiodun John and Matson, Kelly L and Lee, Jung Eun and McCormick, Meghan and Greaney, Mary L and Caffrey, Aisling R},
  title = {Medication Utilization Among Children With Sickle Cell Disease in the United States},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31788}
}
Kostenlos starten →